AR098880A2 - Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusión - Google Patents
Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusiónInfo
- Publication number
- AR098880A2 AR098880A2 ARP140104816A ARP140104816A AR098880A2 AR 098880 A2 AR098880 A2 AR 098880A2 AR P140104816 A ARP140104816 A AR P140104816A AR P140104816 A ARP140104816 A AR P140104816A AR 098880 A2 AR098880 A2 AR 098880A2
- Authority
- AR
- Argentina
- Prior art keywords
- mmol
- concentration
- electrolyte
- protective solution
- contained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una solución protectora para prevenir daños isquémicos en los órganos, o en sistemas celulares aislados, o en componentes de tejido después de la perfusión, operación, trasplante, o crio-conservación y subsiguiente reperfusión, que comprende un electrolito seleccionado del grupo que consiste en iones alcalinos y iones alcalino-térreos, un buffer, un poliol y/o un sacárido, en donde dicha solución tiene una osmolaridad de 290 mosm/L a 350 mosm/L, como también un pH con un valor de 6,8 a 7,4 y comprende ácido 3,4 dimetoxi-N-metiIbenzohidroxámico y/o una sal del mismo, dicha composición además comprende N-acetilhistidina como un agente buffer en combinación con arginina, con un contenido aniónico de aspartato, en la cual el ácido 3,4-dimetoxi-N-metilbenzohidroxámico y/o una sal del mismo está comprendido en una cantidad de hasta 10 mmol/L, en la cual la N-acetilhistidina está comprendida en una concentración de 30 mmol/L a 265 mmol/L, en la cual el sodio está contenido deliberadamente como un electrolito a una concentración de 10 mmol/L a 80 mmol/L, en la cual el potasio está contenido deliberadamente como un electrolito a una concentración de 5 mmol/L a 25 mmol/L, en la cual el magnesio está contenido deliberadamente como un electrolito a una concentración de 3,5 mmol/L a 27 mmol/L, en la cual el calcio está contenido deliberadamente como un electrolito a una concentración de 0,005 mmol/L a 0,095 mmol/L, en donde el aspartato está contenido a una concentración de hasta 140 mmol/L, y en donde el a-cetoglutarato está contenido a una concentración de 1 mmol/L a 9 mmol/L. Reivindicación 2: Solución protectora de acuerdo con la reivindicación 1, caracterizada porque comprende una adición de un derivado del ácido 6-hidroxi-2,5,7,8-tetrametilcromán-2-carboxílico, preferentemente del metil éster respectivo. Reivindicación 3: Solución protectora de acuerdo con una cualquiera de las reivindicaciones precedentes, caracterizada porque tiene un contenido de catión de lisina y/o derivado de lisina, preferentemente dipéptidos que contienen lisina. Reivindicación 5: Solución protectora de acuerdo con una cualquiera de las reivindicaciones 2 a 4, caracterizada porque el derivado del ácido 6-hidroxi-2,5,7,8-tetrametiIcromán-2-carboxílico, preferentemente como el derivado de metil éster, está comprendido en una concentración de hasta aproximadamente 10 mmoI/L.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10222561A DE10222561B4 (de) | 2002-05-17 | 2002-05-17 | Protektive Lösung zur Verhinderung von Ischämieschäden |
Publications (1)
Publication Number | Publication Date |
---|---|
AR098880A2 true AR098880A2 (es) | 2016-06-22 |
Family
ID=29265373
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101726A AR039819A1 (es) | 2002-05-17 | 2003-05-16 | Solucion protectora para evitar danos isquemicos en organos |
ARP140104816A AR098880A2 (es) | 2002-05-17 | 2014-12-19 | Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusión |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101726A AR039819A1 (es) | 2002-05-17 | 2003-05-16 | Solucion protectora para evitar danos isquemicos en organos |
Country Status (13)
Country | Link |
---|---|
US (2) | US7977383B2 (es) |
EP (2) | EP1362511B1 (es) |
JP (1) | JP4603246B2 (es) |
KR (2) | KR101014990B1 (es) |
CN (1) | CN100448440C (es) |
AR (2) | AR039819A1 (es) |
AT (2) | ATE446676T1 (es) |
BR (1) | BRPI0301159B8 (es) |
CA (1) | CA2429097C (es) |
DE (4) | DE10222561B4 (es) |
DK (1) | DK1859679T3 (es) |
ES (2) | ES2362867T3 (es) |
MX (1) | MXPA03004315A (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10222561B4 (de) | 2002-05-17 | 2009-12-10 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
CA2564868C (en) | 2004-04-28 | 2013-11-26 | Molecules For Health, Inc. | Methods for treating or preventing restenosis and other vascular proliferative disorders |
WO2005115141A1 (ja) * | 2004-05-26 | 2005-12-08 | National University Corporation Kagawa University | 希少糖を利用した細胞・組織・臓器保存液及び該液を用いる保存方法 |
DE102007026392A1 (de) * | 2007-06-06 | 2008-12-11 | Bayer Healthcare Ag | Lösungen für die Perfusion und Konservierung von Organen und Geweben |
EP2030615A3 (en) * | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases |
US8835104B2 (en) | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
JP5705324B2 (ja) * | 2010-09-01 | 2015-04-22 | パフュージョン・フルイド・テクノロジーズ・インコーポレイテッドPerfusion Fluid Technologies, Inc. | 灌流組成物 |
WO2012139017A1 (en) | 2011-04-07 | 2012-10-11 | Fenwal, Inc. | Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates |
BRPI1101935B1 (pt) * | 2011-04-15 | 2017-12-12 | Universidade Federal De Minas Gerais | Antioxidant composition for preservation of organs and fabrics |
DE102012005177A1 (de) | 2012-03-16 | 2013-09-19 | Bitop Ag | Organlagerlösung |
CN103238586B (zh) * | 2013-03-28 | 2014-03-26 | 辽宁亿灵科创生物医药科技有限公司 | 一种心肌脏器保存液制备方法 |
EP2821081A1 (en) * | 2013-07-05 | 2015-01-07 | ResuSciTec GmbH | Protective solution for preventing or reducing reperfusion injury of the brain and the whole body |
SI3086793T1 (sl) | 2013-12-24 | 2022-10-28 | Virginia Commonwealth University | Uporaba oksigeniranih holesterol sulfatov (OCS) za zdravljenje ledvične disfunkcije |
WO2017192413A1 (en) | 2016-05-01 | 2017-11-09 | The Regents Of The University Of California | Glutarate compounds for treating ischemia-reperfusion injuries |
DE102016125414A1 (de) | 2016-12-22 | 2018-06-28 | Bitop Ag | Zusammensetzung enthaltend N-Acetyldiaminobuttersäure |
CN110536687B (zh) * | 2018-03-27 | 2022-12-16 | 华东理工大学 | N-羟基吡啶酮类化合物及其用途 |
KR20200069995A (ko) | 2018-12-08 | 2020-06-17 | 이은지 | 접이식 빗자루 |
EP4248959A1 (en) * | 2022-03-22 | 2023-09-27 | Dr. Franz Köhler Chemie GmbH | Preparation for reduction of pathological iron overload |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH639270A5 (de) | 1978-12-14 | 1983-11-15 | Koehler Franz Dr Chemie Kg | Protektive loesung fuer herz und niere. |
ATE11736T1 (de) * | 1980-12-23 | 1985-02-15 | Dr. Franz Koehler Chemie Gmbh | Protektive loesung fuer herz und niere und verfahren zu deren herstellung. |
US4419365A (en) | 1981-12-21 | 1983-12-06 | Ciba-Geigy Corporation | Method of treating Alzheimer's disease |
US4562006A (en) * | 1984-01-11 | 1985-12-31 | Warner-Lambert Company | Cycloheptadiene derivatives |
US4607053A (en) * | 1984-05-17 | 1986-08-19 | E. R. Squibb & Sons, Inc. | Arylhydroxamates useful as antiallergy agents |
US4604407A (en) * | 1985-04-04 | 1986-08-05 | E. R. Squibb & Sons, Inc. | Hydroxamates |
US4927571A (en) * | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
DK36389A (da) | 1988-02-05 | 1989-08-06 | Eastman Kodak Co | Praeparat og fremgangsmaade til at forebygge vaevskader ved reperfusion |
WO1991015215A1 (en) | 1990-03-30 | 1991-10-17 | Biomedical Frontiers, Inc. | Fluid resuscitation |
JPH11514326A (ja) | 1990-03-30 | 1999-12-07 | バイオメディカル フロンティアーズ インコーポレイテッド | 液体蘇生用医薬物 |
JP2768799B2 (ja) | 1990-04-12 | 1998-06-25 | 株式会社大塚製薬工場 | 心筋保護液 |
AU8513191A (en) * | 1990-09-10 | 1992-03-30 | Austin L. Shug | Composition and method for protecting the heart during reperfusion |
JP2860301B2 (ja) | 1990-09-19 | 1999-02-24 | ヘキスト・マリオン・ルセル株式会社 | 臓器保存用溶液 |
GB9024820D0 (en) * | 1990-11-15 | 1991-01-02 | Davies Michael J | Pharmaceutical compositions |
US5498427A (en) * | 1990-11-20 | 1996-03-12 | Pasteur Merieux Serums Et Vaccines | Solutions for the perfusion, preservation and reperfusion of organs |
US5290766A (en) * | 1991-02-18 | 1994-03-01 | The National Heart Foundation Of New Zealand | Cardioplegic compositions |
US5405742A (en) * | 1993-07-16 | 1995-04-11 | Cyromedical Sciences, Inc. | Solutions for tissue preservation and bloodless surgery and methods using same |
EP0713363B1 (en) * | 1993-08-12 | 2002-06-12 | The University Of North Carolina At Chapel Hill | Rinse solution for organs and tissues |
US6321909B1 (en) * | 1997-02-13 | 2001-11-27 | Sky High, Llc | System for storing polyethylene glycol solutions |
EP0938896A1 (en) * | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
US6365338B1 (en) * | 1999-04-27 | 2002-04-02 | David A. Bull | Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source |
DE10222561B4 (de) | 2002-05-17 | 2009-12-10 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
-
2002
- 2002-05-17 DE DE10222561A patent/DE10222561B4/de not_active Expired - Fee Related
- 2002-05-17 DE DE10262084A patent/DE10262084B4/de not_active Expired - Fee Related
-
2003
- 2003-05-14 AT AT07012466T patent/ATE446676T1/de active
- 2003-05-14 DE DE50313573T patent/DE50313573D1/de not_active Expired - Lifetime
- 2003-05-14 EP EP03010783A patent/EP1362511B1/de not_active Expired - Lifetime
- 2003-05-14 ES ES03010783T patent/ES2362867T3/es not_active Expired - Lifetime
- 2003-05-14 DK DK07012466.4T patent/DK1859679T3/da active
- 2003-05-14 AT AT03010783T patent/ATE503383T1/de active
- 2003-05-14 ES ES07012466T patent/ES2335145T3/es not_active Expired - Lifetime
- 2003-05-14 DE DE50312079T patent/DE50312079D1/de not_active Expired - Lifetime
- 2003-05-14 EP EP07012466A patent/EP1859679B1/de not_active Expired - Lifetime
- 2003-05-16 BR BRPI0301159A patent/BRPI0301159B8/pt not_active IP Right Cessation
- 2003-05-16 US US10/438,977 patent/US7977383B2/en not_active Expired - Lifetime
- 2003-05-16 KR KR1020030031134A patent/KR101014990B1/ko active IP Right Grant
- 2003-05-16 JP JP2003138927A patent/JP4603246B2/ja not_active Expired - Fee Related
- 2003-05-16 CA CA2429097A patent/CA2429097C/en not_active Expired - Lifetime
- 2003-05-16 AR ARP030101726A patent/AR039819A1/es not_active Application Discontinuation
- 2003-05-16 CN CNB031438474A patent/CN100448440C/zh not_active Expired - Lifetime
- 2003-05-16 MX MXPA03004315A patent/MXPA03004315A/es active IP Right Grant
-
2010
- 2010-08-11 KR KR1020100077083A patent/KR101061293B1/ko active IP Right Grant
-
2011
- 2011-06-02 US US13/152,056 patent/US9603354B2/en not_active Expired - Lifetime
-
2014
- 2014-12-19 AR ARP140104816A patent/AR098880A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20100093023A (ko) | 2010-08-24 |
AR039819A1 (es) | 2005-03-02 |
JP2004002418A (ja) | 2004-01-08 |
ATE446676T1 (de) | 2009-11-15 |
DK1859679T3 (da) | 2010-03-15 |
MXPA03004315A (es) | 2005-02-14 |
US20110300237A1 (en) | 2011-12-08 |
CN100448440C (zh) | 2009-01-07 |
DE50313573D1 (de) | 2011-05-12 |
KR20030089495A (ko) | 2003-11-21 |
CA2429097C (en) | 2013-06-18 |
EP1859679B1 (de) | 2009-10-28 |
DE50312079D1 (de) | 2009-12-10 |
ES2362867T3 (es) | 2011-07-14 |
DE10262084B4 (de) | 2009-12-24 |
US7977383B2 (en) | 2011-07-12 |
EP1859679A1 (de) | 2007-11-28 |
EP1362511A1 (de) | 2003-11-19 |
BR0301159A (pt) | 2004-08-17 |
KR101014990B1 (ko) | 2011-02-16 |
ES2335145T3 (es) | 2010-03-22 |
ATE503383T1 (de) | 2011-04-15 |
EP1362511B1 (de) | 2011-03-30 |
CN1480132A (zh) | 2004-03-10 |
DE10222561A1 (de) | 2003-12-04 |
US20030215781A1 (en) | 2003-11-20 |
KR101061293B1 (ko) | 2011-08-31 |
BRPI0301159B1 (pt) | 2018-05-15 |
DE10222561B4 (de) | 2009-12-10 |
JP4603246B2 (ja) | 2010-12-22 |
US9603354B2 (en) | 2017-03-28 |
CA2429097A1 (en) | 2003-11-17 |
BRPI0301159B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR098880A2 (es) | Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusión | |
Aisen et al. | Ultramicroscopic and biochemical changes in ram spermatozoa cryopreserved with trehalose-based hypertonic extenders | |
Malo et al. | Anti-oxidant supplementation improves boar sperm characteristics and fertility after cryopreservation: comparison between cysteine and rosemary (Rosmarinus officinalis) | |
Çoyan et al. | Effects of cysteine and ergothioneine on post-thawed Merino ram sperm and biochemical parameters | |
AR072250A1 (es) | COMPOSICIONES DE INSULINA DE ACCION SUPERRAPIDA. BOMBA DE INSULINA, DISPENSADOR. SISTEMA DE LAZO CERRADO. METODO PARA PREPARAR COMPOSICIoN, USO. COMBINACION. KIT. | |
JP2014516981A5 (es) | ||
Öztürk et al. | Cryobiology and cryopreservation of sperm | |
AR095964A1 (es) | Formulaciones para la preservación de órganos y tejidos con mayor estabilidad y vida útil | |
RU2010151977A (ru) | Водный раствор для консервации тканей и органов | |
EA201691066A1 (ru) | Растворы для повышения стабильности и срок годности раствора для консервирования органов и тканей | |
JP3694730B2 (ja) | 組織の冷却保存液 | |
Tomalty et al. | Kidney preservation at subzero temperatures using a novel storage solution and insect ice-binding proteins | |
PE20081321A1 (es) | Composicion microbicida acuosa estabilizada contra la degradacion por luz ultravioleta en frutas o vegetales comestibles | |
JP2007224004A (ja) | 超小型豚の人工授精用精液の希釈保存剤。 | |
KR101546487B1 (ko) | 저밀도 지질단백질과 항산화제를 포함하는 정자 동결보존용 조성물 및 이의 용도 | |
KR20200028412A (ko) | 보존 용액 | |
PE97199A1 (es) | Composiciones solubilizadas de sertralina | |
CU23441A3 (es) | Composición agroquímica en suspensión acuosa | |
RU2010146519A (ru) | Композиция биологически активных препаратов для повышения выживаемости осетровых рыб при искусственном воспроизводстве | |
AR042528A1 (es) | Procedimiento para preparar una composicion acuosa blanqueadora de perborato | |
JP2014198673A (ja) | 動物胚の低温保存用の保存剤及び低温での動物胚の保存方法 | |
Achi et al. | Effect of Vitamin C Levels in Chicken Egg Yolk Extender on Sperm Motility in Chilled Stored Bull Semen | |
Minor | Gaseous oxygen to improve viability of marginal or pre-damaged organ grafts during hypothermic storage | |
UA152369U (uk) | Спосіб кріоконсервування еритроцитів | |
AR091707A1 (es) | Formulaciones estabilizadas de etanercept |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |